Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Systems Immunology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1632426

This article is part of the Research TopicCrosstalk: Skin Cells and Immune Cells in Inflammatory Skin Diseases: Volume 2View all 8 articles

Sulfotransferase SULT2B1 Contributes to the Epithelial–Immune Microenvironment Homeostasis in Imiquimod-Induced Psoriatic Dermatitis

Provisionally accepted
  • 1Kyushu University, Fukuoka, Japan
  • 2Kyoto University, Kyoto, Kyōto, Japan
  • 3Kagoshima University, Kagoshima, Kagoshima, Japan

The final, formatted version of the article will be published soon.

Introduction: Skin protects the body from external threats by constituting an epithelial–immune microenvironment. Sulfotransferase family 2B member 1 (SULT2B1) converts cholesterol to cholesterol sulfate (CS). We previously reported that CS acts as an endogenous dedicator of cytokinesis 2 (DOCK2)-inhibitory metabolite suppressing immune cell migration and activation by inhibiting DOCK2-mediated Rac activation. Despite being located in the epidermis, pathophysiological roles of CS in cutaneous inflammation remain unknown. Methods: We evaluated the Sult2b1-producing cells in the dorsal skin of wild-type mice and compared the degree of cutaneous inflammation between wild-type and Sult2b1 knockout mice using a psoriatic dermatitis model induced by topical imiquimod (IMQ). We also examined SULT2B1 gene expression levels in human epidermal keratinocytes to assess the effects of pro-inflammatory cytokines. Results: Sult2b1 expression levels and CS production gradually increased in the skin of psoriatic dermatitis model mice. IMQ-induced dermatitis and neutrophil recruitment were exacerbated in the Sult2b1 knockout mice with a complete loss of CS. Furthermore, genetic deletion of Dock2 or intravenous administration of neutrophil-depleting antibodies alleviated IMQ-induced dermatitis in Sult2b1 knockout mice. Notably, CS was more abundant in the skin samples of patients with psoriasis than in the healthy control samples. Primary normal human epidermal keratinocytes exhibited significantly elevated SULT2B1 levels after Th1 cytokine treatment. Discussion: These findings suggest that increased SULT2B1 levels in the skin under psoriatic conditions may be involved in a negative feedback mechanism that helps to limit excessive skin inflammation, thereby potentially contributing to the maintenance of epithelial–immune microenvironment homeostasis. Overall, our results raise the possibility that SULT2B1 plays an important role in cutaneous inflammation and could serve as a useful indicator or potential target in psoriasis.

Keywords: SULT2B1, Cholesterol sulfate, DOCK2, Skin inflammation, Psoriasis, Neutrophils

Received: 21 May 2025; Accepted: 06 Oct 2025.

Copyright: © 2025 Morino, Akiyoshi, Matsubara, Sugiura, Izumi, Yotsumoto, Yamamura, Maeda, Takahashi, Nakata, Bamba, Nakahara, Sakata, Uruno, Fukui and Kunimura. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Kazufumi Kunimura, kunimura@bioreg.kyushu-u.ac.jp

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.